Researchers say breast cancer survival improves Herceptin used with chemotherapy

Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin.

Read the whole article on Physorg

More from Physorg